Holmusk signs three-year collaboration with Otsuka to enhance digital health and data analytics

Holmusk announced today that it has entered a three-year collaboration with Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka). Together, Holmusk and Otsuka will work to drive a deeper understanding of unmet patient needs and real-world outcomes by employing proprietary analytics and artificial intelligence (AI) on multiple real-world data sources. These...

Read more...

Alodokter bags fresh funding from MDI Ventures and Samsung Ventures

Alodokter has raised additional funding from existing investor MDI Ventures and new investor Samsung Ventures Investment Corporation (Samsung Ventures). Alodokter will use the funding to continually expand and digitize the healthcare ecosystem as well as develop new products for Alodokter's platform. We look forward to Alodokter continuing strong traction...

Read more...

Heritas Capital announces US$60m first close of Heritas Growth Fund III to back Asian emerging champions driving sustainable Covid-19 recovery

Pan-Asia Impact Fund to back high-growth emerging champions developing smart platforms that enhance access to affordable quality healthcare and education for sustainable post-Covid recovery, in line with UN Sustainable Development Goals (SDGs) Builds on successful track record of earlier Growth Funds which have deployed US$150 million to back...

Read more...

Heritas Capital continues backing Hummingbird Bioscience for its Series C round together with SEEDS Capital

Heritas Capital is pleased to participate, together with SEEDS Capital, in Hummingbird Bioscience’s successful closing of its US$125m Series C financing round led by Novo Holdings alongside other investors including Frazier Healthcare Partners, Octagon Capital, EDBI, AMGEN Ventures, DROIA Ventures, Morningside Ventures, Pureos Bioventures, Polaris Partners, Affinity Asset Advisors,...

Read more...

Holmusk acquires mental health analytics provider Otsuka Health Solutions to expand its UK footprint

Holmusk announced today that it has acquired Otsuka Health Solutions (OHS), a UK-based mental health, predictive analytics provider. The acquisition from Otsuka Pharmaceutical Europe Ltd (Otsuka) deepens Holmusk's footprint in the UK and paves the way for Holmusk to expand its partnerships with health systems working to transform behavioral...

Read more...